-
Preventing avoidable deaths. Essentials and recommendations on opioid overdose. Eurohrn II Project
-
Guidelines for the identification and management of substance use and substance use disorders in pregnancy
-
Models of community and peer-based overdose prevention services: Scotland, Denmark, Italy, Spain, Estonia and Lithuania. Comparative analysis report
-
Guidance on the clinical management of acute and chronic harms of club drugs and novel psychoactive substances
-
Overdose prevention centres, safe consumption sites, and drug consumption rooms: A rapid evidence review
-
Impact of opioid dose escalation on the development of substance use disorders, accidents, self-inflicted injuries, opioid overdoses and alcohol and non-opioid drug-related overdoses: a retrospective cohort study
-
Health and social responses: drug consumption rooms
-
Preventing overdose deaths in Europe
-
SAMHSA Overdose prevention and response toolkit
-
Turning down the alcohol flow. Background document on the European framework for action on alcohol, 2022–2025
-
Pharmacotherapies for cannabis dependence (Review)
-
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence (Review)
-
Pregnancy and opioid use: strategies for treatment
-
Medications for opioid use disorder save lives
-
Frequently asked questions (FAQ): drug overdose deaths in Europe
-
Community Substance Misuse Services Quality Standards Framework
-
Implementation of key demand-reduction measures of the WHO Framework Convention on Tobacco Control and change in smoking prevalence in 126 countries: an association study
-
Le recours aux antalgiques opioïdes dans le traitement de la douleur. Revue de la littérature
-
Impact of drugs on communities
-
Study assessing the effectiveness of overdose prevention centers through evaluation research (SAFER): an overview of the study protocol
-
Macroeconomic conditions and opioid abuse
-
Vital Signs: Drug Overdose Deaths, by Selected Sociodemographic and Social Determinants of Health Characteristics — 25 States and the District of Columbia, 2019–2020
-
Community led monitoring of opioid agonist treatment including WHO quality of life indicators
-
Policy in action. A tool for measuring alcohol policy implementation